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Background: Little is known about the clinical effectiveness of non-amlodipine calcium channel blockers (CCBs) in older adults with heart failure 
and preserved ejection fraction (HF-PEF).
methods: Of the 10,570 hospitalized HF-PEF patients, age ≥65 years, EF ≥40%, in OPTIMIZE-HF (2003-2004), linked to Medicare data (through 
December 31, 2008), 7,514 had no prior history of CCB use, and 302 patients receiving new discharge prescription for amlodipine were excluded. 
Of the remaining 7,212 patients, 513 (7%) patients received new discharge prescriptions for non-amlodipine CCBs. Propensity scores for non-
amlodipine CCB use, calculated for each of 7,212 patients, were used to assemble a cohort of 502 pairs of patients balanced on 114 baseline 
characteristics.
results: Patients had a mean age of 80 years, mean EF of 56%, 66% were women and 8% African American. The primary composite endpoint of 
all-cause mortality or HF hospitalization occurred in 82% and 83% of patients receiving and not receiving non-amlodipine CCBs, respectively (hazard 
ratio {HR}, 1.00; 95% confidence interval {CI}, 0.88-1.15; p=0.963; Figure). Use of non-amlodipine CCB had no association with individual endpoints 
of all-cause mortality and HF hospitalization. Similar multivariable-adjusted and propensity-adjusted associations were observed among 7,212 pre-
match patients.
conclusions: In hospitalized older HF-PEF patients, new prescriptions for non-amlodipine CCBs had no association with clinically outcomes.
